A Tribute to Legendary Emerging Markets Investor – and MoneyShow Partner – Mark Mobius

Mike Larson | Editor-in-Chief

It was with great sadness that we learned recently of the passing of Mark Mobius at the age of 89. A legendary emerging markets investment expert, and tireless advocate of on-the-ground research, Mobius was also a long-time contributor to MoneyShow – one we were honored to work with for decades.

Born to German and Puerto Rican parents in Hempstead, New York, Mobius obtained bachelor’, master’s, and Ph.D degrees from Boston University and the Massachusetts Institute of Technology. He also studied at other universities in Wisconsin, New Mexico, and Japan, before joining the Franklin Templeton money management firm in 1987.

Mobius was a pioneer of EM investing at Franklin, earning the nickname the “godfather of emerging markets.” He travelled to 112 countries during the course of his career to conduct research and see the world, while also authoring more than a dozen books that included Passport to Profits and The Investor’s Guide to Emerging Markets.

“We’ve had the privilege to work with many elite market educators in our 45-year history. But few were as talented, distinguished, and dedicated to their craft as Mark. He was a tireless advocate of global investing – and someone whose relentless passion and thirst for knowledge was unparalleled,” said MoneyShow Chair and CEO Kim Githler. “I’m honored to have known him and will miss him dearly.”

Mobius retired from Franklin Templeton in 2018, but continued his work in the industry, co-founding Mobius Capital Partners that same year. He also managed the Mobius Emerging Opportunities Fund – and shared his insights with MoneyShow investors and traders during a series of live and virtual events.

Here are a couple examples we’re sharing in his memory:

Fireside Chat with Mark Mobius – May 3, 2023

Fireside Chat with Mark Mobius – September 23, 2025

Renick & Roche: What to Know About Investing in the AI Era

May 1 is Your Dallas Discount Deadline. Don’t Miss it!

The 2026 MoneyShow Masters Symposium Dallas is fast approaching – and so is a key deadline!

On May 1, the price of both Standard and Preferred Passes to the event will rise by $100. The cost of add-on MoneyMasters Courses will also go up $50. But you can STILL qualify for “Early Bird” pricing – and beat those increases – by booking here today...

• SPX: Ignore the War Headlines and Focus on Great Earnings
  👉️ TICKERS: BAC, GS, JPM, SPX
  It’s great to be back after a few much-needed days off and a grand 1,500-mile adventure across the American West. The S&P 500 Index (^SPX) has risen 3% three weeks in a row only three times since 1950 if memory serves. In each case, it was overwhelmingly positive a year later by an average of 33%, says Keith Fitz-Gerald, editor of 5 With Fitz.

• ABT: An Attractive Bargain in the Healthcare Sector
  👉️ TICKER: ABT

  Shares of Abbott Laboratories (ABT) are now down more than 22% in 2026. The medical device maker and healthcare products and services provider got no help from its Q1 earnings release. But we continue to think very highly of Abbott and its strong financial position, writes John Buckingham, editor of The Prudent Speculator.

🏙️📈 Get unique market insights and actionable recommendations for this “New World Order” – at the 2026 MoneyShow Masters Symposium Dallas! Click HERE for your pass to the May 14-16 event.